Purpose: to award the base period for clinical research coordinating center for the nida CTN POP: 08/14/2015-08/13/2016.

Ended Definitive Contract Awarded Last action

Contract number
HHSN271201500065C
Awardee
Awarding agency
Obligated
$22,370,685

Award facts

Opportunity
Contract value 57% obligated
  • $22,370,685.32 Current, with exercised options
  • $38,941,527.32 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 3 offers Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Rockville, MD 20850, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00015 -$96,864
Other Administrative Action P00014 $0
Funding Only Action P00013 · Clinical research coordinating center for the nida CTN. N01DA-15-2243. -$82,945
Funding Only Action P00012 -$432,785
Exercise an Option P00011 $470,844
Exercise an Option P00010 $5,807,334
Exercise an Option 9 $427,612
Exercise an Option 8 $4,069,318
Other Administrative Action 7 $0
Exercise an Option 6 $4,069,336
Other Administrative Action 5 · Clinical research coordinating center for the nida CTN. Period of performance: 08/14/2015-08/13/2017. N01DA-15-2243. $0
Other Administrative Action 4 $0
Other Administrative Action 3 $0
Exercise an Option 2 $4,069,381
Other Administrative Action 1 · ; N01DA-15-2243; "clinical research coordinating center for the nida CTN"; POP: 08/14/2015-08/13/2016; purpose: to add the required far clause 52.204-14 to… $0
Original award $4,069,454
Show all 16

About this award

This is a federal contract award to The Emmes Company LLC, a global clinical research organization, by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH). The purpose of the contract is to provide a Clinical Research Coordinating Center for the NIDA Clinical Trials Network. The contract has a ceiling value of $38,941,527.32 and was awarded on August 14, 2015, with a period of performance from August 14, 2015, to August 13, 2016. The contract is a Cost Plus Fixed Fee Definitive Contract, and it is set aside for small businesses. The Emmes Company LLC is the prime contractor for this award and has secured numerous other prime and subcontract federal awards from various NIH institutes, demonstrating its expertise in supporting complex biomedical research initiatives.

Quick answers

Who was awarded contract HHSN271201500065C?

HHSN271201500065C was awarded to The Emmes Company, LLC by National Institute on Drug Abuse (National Institutes of Health) on August 14, 2015.

How much is contract HHSN271201500065C worth?

The government has obligated $22,370,685 on HHSN271201500065C. Its potential value, with all options, is $38,941,527.

Was contract HHSN271201500065C competed?

The extent of competition for HHSN271201500065C was full and open competition after exclusion of sources. The government received 3 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award